ARTICLE | Company News
NeoGenomics sales and marketing update
December 14, 2015 8:00 AM UTC
NeoGenomics launched its NeoLAB Solid Tumor Monitor test to quantify and track genomic abnormalities in tumors and its NeoLAB BTK Inhibitor Acquired Resistance test to predict resistance to Bruton’s t...